PDF Cover

3D Medical Imaging Devices Market

The market for 3D Medical Imaging Devices was estimated at $13.8 billion in 2025; it is anticipated to increase to $20.8 billion by 2030, with projections indicating growth to around $31.2 billion by 2035.

Report ID:DS1801056
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
3D Medical Imaging Devices
Share
Report Summary
Market Data
Methodology
Table of Contents

Global 3D Medical Imaging Devices Market Outlook

Revenue, 2025

$13.8B

Forecast, 2035

$31.2B

CAGR, 2026 - 2035

8.5%

The 3D Medical Imaging Devices industry revenue is expected to be around $13.8 billion in 2026 and expected to showcase growth with 8.5% CAGR between 2026 and 2035. Advanced diagnostic technology with three dimensional medical imaging equipment is fundamental to the quality of care in hospitals and clinics today. There are three main factors which have led to this situation: the increasing prevalence of complex diseases, the increasing need for precise diagnostic methods and the use of image guided treatment techniques. Together 3D medical imaging devices used in oncology and cardiovascular imaging represented 58.2% of all the market requirements. This dominance arises from their application in the determination of cancer progression, in the devising of cancer treatment plans, and in structural heart assessments. By 2025, the 3D CT market was worth 4.86 billion U. S dollars. This significant figure underlines how vital 3D CT scanning continues to be in providing high speed and high resolution 3D imaging. Technological advances in AI, automation and the integration of sophisticated imaging apparatus with the healthcare infrastructure have further highlighted the need for and the clinical utility of three dimensional imaging.

Various forms of 3D medical imaging technology are in use, including 3D CT scans, 3D MRI equipment, 3D ultrasound imaging and hybrid systems which produce high resolution images in three dimensions. This can provide for real time examination of sections of the body as well as enable detailed analysis of images. The high resolution images they provide can be used to aid in more accurate diagnosis and to allow for treatment tailored to the individuals requirements. Key applications where these systems are commonly utilised include the fields of oncology, cardiovascular medicine, neurology, orthopedics and emergency medicine. These facilities allow for early disease diagnosis, precise characterisation of lesions and the use of more minimally invasive methods which are guided by detailed images of the body's structure and function. The trend of the medical imaging sector involves a combination of ML enabled imaging software for enhanced image detection and segmentation and also techniques aimed at minimising the exposure dose to the patient. This increasing trend has led to improved compatibility with storage systems and cloud services, accelerating the pace at which advanced equipment is being adopted. The shift is being led by the need for value based, data driven healthcare models.

3D Medical Imaging Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
3D Medical Imaging Devices Market Outlook

Market Key Insights

  • The 3D Medical Imaging Devices market is projected to grow from $13.8 billion in 2025 to $31.2 billion in 2035. This represents a CAGR of 8.5%, reflecting rising demand across Oncology, Cardiovascular, and Neurological.

  • Key companies operating in this medical imaging equipment market are Philips, Siemens and Esaote. These companies influence the competitive landscape.

  • The United States and Japan are the two largest 3D medical imaging devices markets and should display growth rates ranging from 6.2% to 8.9% annually from 2025 to 2030.

  • The highest growth rate is expected to occur in emerging markets, such as Brazil, India and South Africa with a compound growth rate ranging from 8.2% to 10.6%.

  • By 2030, the $2 billion revenue growth of the three dimensional medical imaging devices market is anticipated to be fuelled by integration with AI.

  • The three dimensional medical imaging devices sector is expected to expand by $17.4 billion in the period between 2025 and 2035. Cardiovascular and neurological applications are set to claim a larger share of the market, which will be manufactured by these firms.

  • Advances in medical imaging technology coupled with the ageing population are expected to drive a 126% growth rate for 3D medical imaging devices between 2025 and 2035.

3d medical imaging devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
3D Medical Imaging Devices - Country Share Analysis

Opportunities in the 3D Medical Imaging Devices

Indian cancer treatment centres have to deal with increasing patient intake, however, limited access to high resolution three dimensional medical imaging technology inhibits early cancer diagnosis. Despite larger cities having access to high priced medical imaging technology, towns with smaller populations have very limited access to similar equipment. This means There is also an opportunity for PET CT and MRI scanners costing less than high field MRI machines. The oncology applications are set to drive significant growth in the field of diagnostic imaging. It is predicted that the diagnostic imaging market will rise from $3.92 billion in 2025 to $6.15 billion in 2030. This growth will be led by applications which specialise in oncology.

Growth Opportunities in North America and Asia-Pacific

The main driver of demand for 3D medical imaging systems in North America will continue to be oncology applications, driven by extensive cancer screening programs, by efforts to achieve precision in cancer treatment and by the rapid introduction of AI technology for the analysis of medical images in all the big hospital groups and in outpatient clinics. Key region's for growth are in workflows which combine radiotherapy planning systems with diagnostic imaging technology and in extending the use of advanced imaging technology in hospitals which specialise in cancer treatment and outpatient clinics that specialise in cancer treatment. The market is highly competitive, with established international companies under pressure from smaller agile imaging software providers and specialist 3D radiology equipment manufacturers. These latter firms have responded by using cloud technology, decision making tools and subscription services to differentiate their products. The region is characterised by the implementation of schemes which pay for high end MRI and CT scanners, it also has strong clinical research industries and many upgrades to 3D imaging systems are being made.
In the Asia Pacific, 3D medical imaging technology for the heart will be particularly in demand due to a significant increase in heart conditions, large patient groups who are at risk and improvements in cardiac care treatments provided in hospitals. Hospitals in the middle market would greatly benefit from cost reduced 3D diagnostic imaging technology. There is also potential for smaller, more affordable portable cardiac diagnostic devices for those who need them in less populated regions. Furthermore there could be benefit from devices that could do two different kinds of diagnostic tests. Global industry leaders are in a competitive environment with quickly advancing car manufacturers in various regions including China, India, Japan and South Korea. These companies use techniques such as the manufacture of goods on a local scale, the creation of multiple value tiers of product, and selling products as a package. Market driving factors include a growing number of hospitals which are equipped with the latest technology due to government backed investments and a rise in private healthcare spending. Furthermore, training opportunities for cardiologists and radiologists are increasing as well as the acceptance of medical imaging technology which can interpret images.

Market Dynamics and Supply Chain

01

Driver: Increasing Prevalence of Chronic Diseases Combined With Rapid Technological Advancements in Imaging Resolution

The 3D medical imaging devices market is also driven by the rising global burden of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders that require advanced imaging for early detection, precise staging, and effective treatment planning. This trend is also accelerating hospital and diagnostic center demand for high‑resolution 3D CT, MRI, and Positron Emission Tomography‑Computed Tomography (PET-CT) systems capable of detailed anatomical visualization and improved clinical outcomes. At the same time, rapid technological advancements are also expanding device capabilities with enhanced image quality, faster scan times, and integration of artificial intelligence and machine learning algorithms. AI‑based tools automate image reconstruction, enhance anomaly detection, and reduce interpretation times, boosting diagnostic accuracy and workflow efficiency. Together, these factors expand the utility of 3D imaging devices across clinical applications and increase adoption in healthcare settings worldwide.
A key driver of market growth is also the integration of artificial intelligence and machine learning into 3D medical imaging systems, enabling automated analysis, advanced image reconstruction, and improved diagnostic precision. AI‑assisted segmentation and pattern recognition help clinicians detect subtle abnormalities that traditional imaging may also miss, while reducing interpretation workload and turnaround times in radiology departments. These innovations support faster clinical decision‑making and facilitate complex applications such as tumor delineation and cardiovascular assessment. The trend also includes cloud‑based imaging platforms that enable remote access, collaborative diagnostics, and secure data sharing across healthcare networks, further enhancing operational efficiency and extending the reach of 3D imaging technologies to diverse care environments. 
02

Restraint: High Equipment and Operational Costs Limiting Adoption in Budget‑Constrained Healthcare Facilities

The substantial capital investment required for advanced 3D medical imaging devices such as CT scanners, MRI systems, and hybrid platforms significantly restrains market expansion, particularly in smaller hospitals and clinics with limited budgets. High purchase prices, expensive infrastructure setup, and ongoing maintenance fees discourage procurement, often delaying technology upgrades or forcing reliance on older 2D systems. This financial burden reduces demand from resource‑constrained providers, suppresses revenue growth for manufacturers, and slows wider geographic penetration of cutting‑edge imaging technologies.
03

Opportunity: Integration of 3D medical imaging devices into AI-driven radiology networks across Western European healthcare systems and Expanding use of 3d Medical Imaging Devices for orthopedic and spine surgical planning in United States hospitals

The consolidation of radiology facilities in western Europe has presented an opportunity for the integration of 3D imaging devices into cloud based AI powered networks for imaging. The efficient distribution of medical images between different healthcare facilities requires the standardised sharing of data, three dimensional reconstruction and reporting. This approach is thought to help regions deal with a shortage of radiologists and make the most of the capabilities they have in radiology. Software centric medical imaging platforms for three dimensional medical imaging are to be favoured. Western Europe is predicted to have one of the highest rates of adoption of 3D medical imaging systems across the region. These platforms integrate MRI, CT and ultrasound imaging data. Enterprise wide 3D imaging and analytics will be built into these systems.
With rising demand, US orthopaedic and spine centers are looking to high volume 3D medical imaging in order to more effectively assess patients pre operatively and guide them intra operatively. With an increasing move towards three dimensional radiology, there is a growing demand for the corresponding 3D radiology equipment. This shift is particularly observed in complex procedures involving joint replacement or deformation correction. In the five year period spanning 2025 to 2030, revenues for hardware in the global medical imaging equipment market is projected to be increasing to $7.52 billion. This increase from $4.86 billion is being driven by CT and cone beam systems focused on orthopaedics in North America, which are likely to see the fastest growth in sales.
04

Challenge: Shortage of Skilled Personnel and Technical Complexity Hindering Effective Utilization and Market Integration

The effective operation and interpretation of 3D imaging systems require highly trained radiologists and imaging technologists, creating a bottleneck in deployment and utilization. Many healthcare facilities, especially in emerging markets, face a shortage of skilled professionals, which limits the ability to fully leverage advanced 3D imaging capabilities. This talent gap leads to underutilization of installed devices, longer training periods, and slower adoption rates, affecting overall market growth and clinical workflow efficiency. 

Supply Chain Landscape

1

Imaging Components

Hamamatsu PhotonicsTeledyne DALSA
2

3D Medical-Imaging Devices

Siemens HealthineersGE Healthcare Ltd.Koninklijke Philips N.V
3

Radiology Distribution

Agiliti HealthAvante Health Solutions
4

Clinical Applications

Hospitals & ClinicsDiagnostic Imaging CentersResearch & Academic Institutes
3D Medical Imaging Devices - Supply Chain

Use Cases of 3D Medical Imaging Devices in Oncology & Neurological

Oncology : In oncology, 3D medical imaging devices such as PET‑CT, CT scanners, and MRI systems are essential for detecting, staging, and monitoring tumors with high resolution and anatomical accuracy. PET‑CT hybrid imaging combines metabolic and structural data to guide precision treatment planning and evaluate therapeutic responses, especially in complex cancers. These advanced imaging technologies enable clinicians to identify small lesions early, improving outcomes. Hospitals and cancer centers rely on solutions from GE Healthcare, Siemens Healthineers, and Philips Healthcare, known for their strong portfolios, AI‑enhanced visualization software, and global service networks that enhance diagnostic confidence and care coordination.
Cardiovascular : For cardiovascular applications, 3D CT angiography and cardiac MRI devices provide detailed visualization of heart structures, blood vessels, and functional assessments, supporting diagnosis and management of coronary artery disease, congenital defects, and cardiac dysfunction. 3D ultrasound also plays a growing role in real‑time cardiac imaging at point‑of‑care settings, offering radiation‑free assessment of cardiac anatomy and function. Leading providers like GE Healthcare, Canon Medical Systems, and Philips Healthcare drive innovation with AI‑powered reconstruction tools, dose‑optimized protocols, and portable solutions that improve workflow efficiency, patient safety, and diagnostic precision across cardiac care environments.
Neurological : 3D medical imaging devices including advanced MRI and CT systems are widely used in neurological diagnosis to visualize brain anatomy, detect strokes, tumors, and neurodegenerative conditions, and support surgical planning. Functional MRI and 3D brain mapping enhance evaluation of neural pathways, improving treatment strategies for epilepsy and movement disorders. Providers such as Siemens Healthineers, GE Healthcare, and Philips Healthcare lead with high‑resolution imaging platforms, integrated AI analytics, and comprehensive neuroimaging software that streamline workflows and support multidisciplinary care in neurology departments and research institutions.

Recent Developments

The 3D medical imaging devices market is rapidly advancing with innovations in AI‑enhanced image reconstruction and portable CT Scan and MRI platforms that improve diagnostic workflow and patient care. Key market trends include integration of cloud‑based PACS and AI‑assisted analytics for faster, more accurate 3D visualization in oncology, cardiovascular, and neurological applications. Vendors are focusing on hybrid imaging modalities and compact, point‑of‑care solutions that extend access to high‑resolution volumetric imaging in decentralized healthcare settings.

May 2025 : GE HealthCare received FDA 510(k) clearance for CleaRecon DL, an AI‑powered deep‑learning tool that significantly improves Cone‑Beam CT image quality and reduces streak artifacts.
November 2025 : Philips Healthcare deployed AI‑powered 3D CT scanners in 50 UAE hospitals, improving diagnostic speed and maintaining high image quality standards.

Impact of Industry Transitions on the 3D Medical Imaging Devices Market

As a core segment of the Medical Device industry, the 3D Medical Imaging Devices market develops in line with broader industry shifts. Over recent years, transitions such as AI Integration in Imaging and Shift towards Portable Devices have redefined priorities across the Medical Device sector, influencing how the 3D Medical Imaging Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

AI Integration in Imaging

The main driver for growth in the 3D medical imaging technology industry is AI based imaging. This is leading to the competitive advantage being in the algorithms that are used in the devices, rather than in the hardware itself. This is also leading to better outcomes for patients and greater efficiency. Companies which are embedding AI and ML algorithms into their 3D medical imaging products are in a position to allow for quicker image reconstruction and also automatically separate images into different parts. This is making the diagnosis more accurate and at the same time also reduces the workload on radiologists and decreases the time taken to go from a scan to a diagnosis. The shift involves the economic transformation of healthcare, thanks to the integration of AI into medical imaging. This will likely result in a $2 billion market growth by the year 2030. Healthcare providers will increasingly focus on AI enhanced 3D imaging solutions that improve efficiency, utilise available resources more effectively and support the value based care models that are currently being used. Those players who speed up the industrialisation of cloud enabled image analysis, decision support tools and AI based imaging workflows will be able to capture a greater market share.
02

Shift towards Portable Devices

The shift toward portable 3D medical imaging devices is transforming diagnostic workflows by enabling point‑of‑care imaging in hospitals, clinics, and remote settings. Compact CT, MRI, and ultrasound systems allow clinicians to perform high-resolution scans outside traditional radiology departments, improving patient accessibility and reducing examination turnaround times. This transition benefits critical care, emergency medicine, and oncology by providing rapid imaging for urgent diagnoses and treatment planning. In associated industries such as orthopedic surgery and cardiovascular interventions, portable 3D imaging facilitates intraoperative guidance, precise implant placement, and minimally invasive procedures. Companies like GE Healthcare, Siemens Healthineers, and Philips Healthcare are investing in lightweight, battery-powered systems with cloud connectivity and AI-assisted reconstruction, extending the utility of 3D imaging beyond conventional radiology labs and supporting broader adoption across diverse healthcare environments.